Sign in to FlowVella

Forgot password?
Sign in with Facebook

New? Create your account

Sign up for FlowVella

Sign up with Facebook

Already have an account? Sign in now


By registering you are agreeing to our
Terms of Service

Share This Flow

Loading Flow

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

- Gastrointestinal perforation, some cases fatal, has occurred in up to 3.2% of bevacizumab-treated patients. Discontinue bevacizumab if gastrointestinal perforation or wound dehiscence occurs. 

- Discontinue at least 28 days prior to elective surgery.

- Do not initiate bevacizumab for at least 28 days after surgery and until the surgical wound is fully healed.

Black box warring of bevacizumab

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

  • 1

  • 2

  • 3

  • 4

  • 5

  • 6

  • 7

  • 8

  • 9

  • 10

  • 11

  • 12

  • 13

  • 14

  • 15

  • 16

  • 17

  • 18

  • 19

  • 20

  • 21

  • 22

  • 23

  • 24

  • 25

  • 26

  • 27

  • 28

  • 29

  • 30

  • 31

  • 32

  • 33

  • 34

  • 35

  • 36

  • 37

  • 38

  • 39

  • 40

  • 41

  • 42

  • 43

  • 44

  • 45

  • 46

  • 47

  • 48

  • 49

  • 50

  • 51

  • 52

  • 53

  • 54

  • 55

  • 56

  • 57

  • 58

  • 59

  • 60

  • 61

  • 62

  • 63

  • 64

  • 65

  • 66

  • 67

  • 68

Lung cancer🚬

By Reem Ayyad

What you know about lung cancer?! It can affect you even you are NOT smoking ..! Learn more about it.